F-Prime
Portfolio in United States: 3 funded startups tracked by Uback, 3 of them in a ranking.
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Xaira Therapeutics | #3 AI drug discovery | Healthtech › Biotech › AI drug discovery | Launch financing · USD 1B+ committed · Apr 2024 | Unicorn |
| Ashby | #4 Recruiting | Business software › HR › Recruiting | Series D · USD 50M · Jul 2025 | Hundreds of M$ |
| SPRY | #11 Clinic management | Healthtech › Clinical software › Clinic management | Series B · USD 15M · Oct 2024 | Tens of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
Co-investors
ARCH Venture Partners · Foresite Labs · NEA · Sequoia Capital · Lux · Lightspeed · Flourish Ventures · Eight Roads · Alkeon Capital · Lachy Groom · Elad Gil
Investors that joined the same rounds, as reported by public sources.
Sources. biospace.com, fiercebiotech.com, indianstartupnews.com, news.crunchbase.com, prnewswire.com, as cited on each company’s profile.
Last updated: Sep 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.